Skip to main content
Log in

Anti-thrombin-III reduction and posterior reversible encephalopathy syndrome (PRES) in acute lymphoblastic leukaemia (ALL). New insight into PRES pathophysiology

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Roth C, Ferbert A (2011) The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol 11(3):136–144

    Article  CAS  Google Scholar 

  2. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500

    Article  CAS  Google Scholar 

  3. Jaing TH, Lin JL, Lin YP, Yang SH, Lin JJ, Hsia SH (2009) Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 31(12):955–956

    Article  Google Scholar 

  4. Piccin A, Cortelazzo S, Rovigatti U, Bourke B, Smith OP (2010) Immunosuppressive treatments in Crohn’s disease induce myelodysplasia and leukaemia. Am J Hematol 85(8):634

    Article  Google Scholar 

  5. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N (2002) Comparison of Escherichia coli–asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children’s Leukemia Group phase 3 trial. Blood 99(8):2734–2739

    Article  CAS  Google Scholar 

  6. Incecik F, Hergüner MO, Altunbasak S, Erbey F, Leblebisatan G (2009) Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurol India 57(4):475–478

    Article  Google Scholar 

  7. Shim YS, Park CO, Hyun DK, Park HC, Yoon SH (2007) What are the causative factors for a slow, progressive enlargement of a chronic subdural hematoma? Yonsei Med J 48(2):210–217

    Article  Google Scholar 

  8. Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, Gnant MF, Alexander HR (2002) Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100(4):1334–1339

    Article  CAS  Google Scholar 

  9. Tanaka M, Yamanishi H (1993) The expression of tissue factor antigen and activity on the surface of leukemic cells. Leuk Res 17(2):103–111

    Article  CAS  Google Scholar 

  10. Attarbaschi A, Mann G, Kronberger M, Witt V, Gadner H, Dworzak M (2003) Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000. Klin Padiatr 215(6):321–326

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea Piccin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piccin, A., Dossi, R.C., Cassibba, V. et al. Anti-thrombin-III reduction and posterior reversible encephalopathy syndrome (PRES) in acute lymphoblastic leukaemia (ALL). New insight into PRES pathophysiology. Ann Hematol 91, 1153–1155 (2012). https://doi.org/10.1007/s00277-011-1376-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1376-z

Keywords

Navigation